These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3705727)

  • 1. [Use of monkeys as a model to evaluate the efficacy of microbial biopreparations in diseases related to dysbacteriosis].
    Dzhikidze EK; Shaginian SA; Pospelova VV; Rakhimova NG; Khaleneva MP
    Vestn Akad Med Nauk SSSR; 1986; (3):74-7. PubMed ID: 3705727
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intestinal dysbacteriosis in yersiniosis patients and the possibility of its correction with biopreparations].
    Kuznetsov VF; Iushchuk ND; Iurko LP; Nabokova NIu
    Ter Arkh; 1994; 66(11):17-8. PubMed ID: 7900004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of various diseases complicated by dysbacteriosis of the intestines].
    Krasnogolovets VN
    Klin Med (Mosk); 1970 May; 48(5):54-9. PubMed ID: 4915000
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of efficacy of the use of coli-Proteus bacteriophage in intestinal dysbacteriosis in premature infants].
    Litvinova AM; Chtetsova VM; Kavtreva IG
    Vopr Okhr Materin Det; 1978 Sep; 23(9):42-4. PubMed ID: 716289
    [No Abstract]   [Full Text] [Related]  

  • 5. [Colibacterin in intestinal diseases associated with dysbacteriosis].
    Pospelova VV; D'iakova EI; Vil'shanskaia FL
    Klin Med (Mosk); 1970 May; 48(5):59-61. PubMed ID: 4915001
    [No Abstract]   [Full Text] [Related]  

  • 6. [Distribution of intestinal dysbacteriosis among children].
    Krivogorskiĭ EB; Meshcherekova KM; Malkina RD; Mikitina RV
    Vopr Okhr Materin Det; 1974 May; 19(5):89. PubMed ID: 4464651
    [No Abstract]   [Full Text] [Related]  

  • 7. [Correction of intestinal dysbacteriosis with biological preparations in acute leukemia].
    Tolkacheva TV; Abakumov EM; Martynova VA; Golosova TV
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):29-33. PubMed ID: 7279892
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunoglobulin and lysozyme content in the intestines during correction of the dysbacteriosis of acute leukemia patients].
    Martynova VA; Tolkacheva TV; Abakumov EM; Golosova TV
    Vopr Onkol; 1981; 27(7):39-43. PubMed ID: 6943866
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quantitative content of Bacteroides in normal human intestines and in dysbacteriosis].
    Petrakov AA; Vil'shanskaia FL; Gavrilov AF
    Mikrobiol Zh (1978); 1983; 45(1):46-50. PubMed ID: 6855641
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intestinal microflora of monkeys, normal and in pathology, and its correction by preparations of live bacteria from human biocenosis (coli bacteria, bifikol and bifidum bacterin)].
    Dzhikidze EK; Shaginian SA; Pospelova VV; Rakhimova NG; Voroshilina NN
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Dec; (12):44-8. PubMed ID: 6397016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental animal models and human disease.
    Gorbach SL; Onderdonk A
    Gastroenterology; 1979 Mar; 76(3):643-5. PubMed ID: 428718
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of sporulating bacteria in treating patients with dysbacteriosis].
    Voĭchishina LG; Chaplinskiĭ VIa; V'iunitskaia VA
    Vrach Delo; 1991 Dec; (12):73-5. PubMed ID: 1792782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological aspects of intestinal dysbacteriosis].
    Zhukov NA; Gusareov AI
    Ter Arkh; 1980; 52(2):82-6. PubMed ID: 7376105
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intestinal dysbacteriosis and its clinical significance].
    Beiul EA; Kuvaeva IB
    Klin Med (Mosk); 1986 Nov; 64(11):37-44. PubMed ID: 3821033
    [No Abstract]   [Full Text] [Related]  

  • 15. [Microbial intestinal biocenosis in lingering and complicated course of community pneumonia].
    Osipov MIu; Bilev AE; Osipov IuA
    Ter Arkh; 2008; 80(2):52-7. PubMed ID: 18372597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy of flonivin BS in the treatment of intestinal dysbacteriosis].
    Polozhenkova LA; Burkov SG; Bokeriia OA; Novikov SV
    Klin Med (Mosk); 1999; 77(2):40-3. PubMed ID: 10380460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intestinal dysbiosis (dysbacteriosis) and/or "excessive bacterial growth syndrome"].
    Tsimmerman IaS
    Klin Med (Mosk); 2005; 83(4):14-22. PubMed ID: 15941136
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of probiotics in humans].
    Bouhnik Y; Marteau P; Rambaud JC
    Ann Gastroenterol Hepatol (Paris); 1993 Oct; 29(5):241-9. PubMed ID: 8250519
    [No Abstract]   [Full Text] [Related]  

  • 19. Intestinal methanogenesis in primates--a genetic and evolutionary approach.
    Hackstein JH; Van Alen TA; Op Den Camp H; Smits A; Mariman E
    Dtsch Tierarztl Wochenschr; 1995 Apr; 102(4):152-4. PubMed ID: 7555692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intestinal dysbacteriosis].
    Dzhordzhadze NS; Krasnogolovets VN
    Med Sestra; 1981 May; 40(5):14-7. PubMed ID: 6910573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.